These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31379747)

  • 21. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer.
    Mazumder S; Mitra Ghosh T; Mukherjee UK; Chakravarti S; Amiri F; Waliagha RS; Hemmati F; Mistriotis P; Ahmed S; Elhussin I; Salam AB; Dean-Colomb W; Yates C; Arnold RD; Mitra AK
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment.
    Dadwal UC; Chang ES; Sankar U
    Front Endocrinol (Lausanne); 2018; 9():335. PubMed ID: 29967592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation.
    Song F; Zhang Y; Pan Z; Hu X; Yi Y; Zheng X; Wei H; Huang P
    Cancer Cell Int; 2021 Oct; 21(1):559. PubMed ID: 34696780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long‑term exposure to leptin enhances the growth of prostate cancer cells.
    Noda T; Kikugawa T; Tanji N; Miura N; Asai S; Higashiyama S; Yokoyama M
    Int J Oncol; 2015 Apr; 46(4):1535-42. PubMed ID: 25625287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
    Chen WY; Tsai YC; Yeh HL; Suau F; Jiang KC; Shao AN; Huang J; Liu YN
    Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling.
    Wu J; Sun H; Yang X; Sun X
    Clin Transl Oncol; 2018 Oct; 20(10):1302-1313. PubMed ID: 29594945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
    Li W; Li S; Yang J; Cui C; Yu M; Zhang Y
    Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876
    [No Abstract]   [Full Text] [Related]  

  • 31. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
    Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
    Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
    Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
    Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
    Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
    Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells.
    Tang Q; Cheng B; Dai R; Wang R
    Front Cell Dev Biol; 2021; 9():729498. PubMed ID: 34692685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.
    Wang C; Wang L; Su B; Lu N; Song J; Yang X; Fu W; Tan W; Han B
    Prostate; 2014 May; 74(7):689-701. PubMed ID: 24619958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.
    Liang J; Li X; Li Y; Wei J; Daniels G; Zhong X; Wang J; Sfanos K; Melamed J; Zhao J; Lee P
    Am J Cancer Res; 2015; 5(3):1124-32. PubMed ID: 26045991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.
    Yu P; Duan X; Cheng Y; Liu C; Chen Y; Liu W; Yin B; Wang X; Tao Z
    Int J Mol Med; 2017 Nov; 40(5):1426-1434. PubMed ID: 28901378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion.
    Yu Y; Zhang Q; Ma C; Yang X; Lin R; Zhang H; Liu Y; Han Z; Cheng J
    Stem Cell Res Ther; 2018 Sep; 9(1):242. PubMed ID: 30257726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.